The invention relates to fusion proteins which comprise at least one antigenic amino acid sequence fused to a carrier heterologous protein sequence, wherein the antigenic sequence comprises an epitopic sequence of a Plasmodium protein and the carrier heterologous protein sequence is a sequence that is immunogenic in humans. The proteins are useful as anti-malaria vaccines.本發明係關於包括至少一個融合至載體異源蛋白序列之抗原性胺基酸序列之融合蛋白,其中該抗原性序列包括瘧原蟲屬(Plasmodium)蛋白之表位序列且該載體異源蛋白序列係在人類中具有免疫原性之序列。該等蛋白質可用作抗瘧疾疫苗。
